Accepted for Publication: September 8, 2021.
Published: November 15, 2021. doi:10.1001/jamanetworkopen.2021.33090
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Oskotsky T et al. JAMA Network Open.
Corresponding Authors: Marina Sirota, PhD, Bakar Computational Health Sciences Institute, University of California, San Francisco, 490 Illinois St, 2nd Floor, PO Box 2933, San Francisco, CA 94143 (email@example.com); David K. Stevenson, MD, Center for Academic Medicine, Stanford University School of Medicine, 453 Quarry Rd, Stanford, CA 94304 (firstname.lastname@example.org).
Author Contributions: Dr T. Oskotsky had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Drs T. Oskotsky and Marić are co–first authors. Drs Sirota and Stevenson are co–senior authors.
Concept and design: T. Oskotsky, Marić, Wong, Sirota, Stevenson.
Acquisition, analysis, or interpretation of data: T. Oskotsky, Marić, Tang, B. Oskotsky, Aghaeepour, Sirota, Stevenson.
Drafting of the manuscript: T. Oskotsky, Marić, Sirota.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: T. Oskotsky, Tang, Aghaeepour, Sirota.
Obtained funding: Tang, Sirota, Stevenson.
Administrative, technical, or material support: T. Oskotsky, Marić, B. Oskotsky, Wong, Stevenson.
Supervision: T. Oskotsky, Sirota, Stevenson.
Conflict of Interest Disclosures: Dr Sirota reported serving as a scientific advisor at Aria Pharmaceuticals, Inc. No other disclosures were reported.
Funding/Support: This study was supported by the Christopher Hess Research Fund and in part by the University of California, San Francisco, Program for Breakthrough Biomedical Research grant, grant T32GM007618 from the Medical Scientist Training Program, and grant R35GM138353 from the National Institutes of Health.
Role of the Funder/Sponsor: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We thank members of the Sirota Lab, University of California, San Francisco, for useful discussion. We also thank Cheryl Akridge, BA, Gary Gasperino, MS, Keenan Crane, BS, and Stacey Purinton, MSN, along with everyone on the Cerner Clinical Research Team, for providing access to the Cerner Real World COVID-19 deidentified database and technical assistance; these individuals were not compenstated for their contributions.
N , Sánchez-Rico
M , Vernet
et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry
. Published online February 4, 2021. doi:10.1038/s41380-021-01021-4Google Scholar
PA , Stafford
RS , Singer
DE . Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care. Prim Care Companion J Clin Psychiatry
. 2003;5(4):153-157. doi:10.4088/PCC.v05n0402
Y , Kataoka
Y , Ostinelli
EG , Cipriani
A , Furukawa
TA . National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis. Front Psychiatry
. 2020;11:35. doi:10.3389/fpsyt.2020.00035
J , DellaGioia
N , Bloch
M . The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology
. 2011;36(12):2452-2459. doi:10.1038/npp.2011.132
S , Medghalchi
M , Gregory
B , Brennan
F , Williams
R . Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Arthritis Rheum
. 2010;62(3):683-693. doi:10.1002/art.27304
N , Sánchez-Rico
M , Gulbins
et al; AP-HP / Université de Paris / INSERM COVID-19 research collaboration, AP-HP COVID CDR Initiative, “Entrepôt de Données de Santé” AP-HP Consortium. Association between FIASMAs and reduced risk of intubation or death in individuals hospitalized for severe COVID-19: an observational multicenter study. Clin Pharmacol Ther
. Published online May 29, 2021. doi:10.1002/cpt.2317PubMedGoogle Scholar
N , Sánchez-Rico
M , Gulbins
et al. Association between psychotropic medications functionally inhibiting acid sphingomyelinase and reduced risk of intubation or death among individuals with mental disorder and severe COVID-19: an observational study. medRxiv
. Preprint posted online February 20, 2021. doi:10.1101/2021.02.18.21251997Google Scholar
Wang QQ, Xu R, Volkow ND. Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States. World Psychiatry
. Published online October 7, 2020. Accessed September 3, 2021. https://onlinelibrary.wiley.com/doi/full/10.1002/wps.20806
C , Iglesias-González
M , Giralt-López
et al. Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients. Acta Psychiatr Scand
. 2021;143(6):526-534. doi:10.1111/acps.13304
C , Busse
R , Spoden
et al. 6-Month follow up of 8679 hospitalized COVID-19 patients in Germany: a nationwide cohort study. medRxiv
. Preprint posted online April 24, 2012. doi:10.1101/2021.04.24.21256029Google Scholar
E , Altman
DG , Egger
M , Pocock
SJ , Gøtzsche
PC , Vandenbroucke
JP ; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet
. 2007;370(9596):1453-1457. doi:10.1016/S0140-6736(07)61602-X
TA , Cipriani
A , Cowen
PJ , Leucht
S , Egger
M , Salanti
G . Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry
. 2019;6(7):601-609. doi:10.1016/S2215-0366(19)30217-2
MGM , Hagag
RS . The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients. Med Hypotheses
. 2020;144:110140. doi:10.1016/j.mehy.2020.110140
CA , Freitas
TH , Stubbs
et al. Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis. Mol Neurobiol
. 2018;55(5):4195-4206. doi:10.1007/s12035-017-0632-1PubMedGoogle Scholar